CLINICAL TRIALS PROFILE FOR CLINDAMYCIN PHOSPHATE
✉ Email this page to a colleague
All Clinical Trials for CLINDAMYCIN PHOSPHATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00160394 ↗ | Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris | Completed | GlaxoSmithKline | Phase 4 | 2004-12-01 | Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity. |
NCT00160394 ↗ | Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris | Completed | Stiefel, a GSK Company | Phase 4 | 2004-12-01 | Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity. |
NCT00219570 ↗ | Dalacin-T Gel Post Approval Study | Completed | Acronet | Phase 4 | 2005-01-01 | To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel. |
NCT00219570 ↗ | Dalacin-T Gel Post Approval Study | Completed | Bellsystem24 , Inc. | Phase 4 | 2005-01-01 | To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel. |
NCT00219570 ↗ | Dalacin-T Gel Post Approval Study | Completed | Mitsubishi Kagaku Bio-Clinical Laboratories, inc | Phase 4 | 2005-01-01 | To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel. |
NCT00219570 ↗ | Dalacin-T Gel Post Approval Study | Completed | Parexel | Phase 4 | 2005-01-01 | To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CLINDAMYCIN PHOSPHATE
Condition Name
Clinical Trial Locations for CLINDAMYCIN PHOSPHATE
Trials by Country
Clinical Trial Progress for CLINDAMYCIN PHOSPHATE
Clinical Trial Phase
Clinical Trial Sponsors for CLINDAMYCIN PHOSPHATE
Sponsor Name